Shine Drug Patent Portfolio

Shine owns 1 orange book drug protected by 1 US patent Given below is the list of Shine's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5431900 Ester-substituted diaminedithiols and radiolabeled complexes thereof 11 Jul, 2012 Expired


Shine's Family Patents


Family Patents





Clinical Trials

Recent Clinical Trials by Shine:

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid Tumors Sunshine Lake Pharma Co., Ltd. NA RECRUITING
(Sep 1, 2026)
PHASE1
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer Sunshine Lake Pharma Co., Ltd. NA RECRUITING
(Aug 1, 2026)
PHASE3
A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B Sunshine Lake Pharma Co., Ltd. NA RECRUITING
(Aug 1, 2026)
PHASE1
A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. NA NOT YET RECRUITING
(Jul 1, 2026)
PHASE2
Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged ≥2 Years. Nanjing Zenshine Pharmaceuticals NA NOT YET RECRUITING
(Jul 1, 2026)
PHASE3
Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative Sunshine Lake Pharma Co., Ltd. NA COMPLETED
(May 1, 2026)
PHASE1, PHASE2
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML Sunshine Lake Pharma Co., Ltd. NA RECRUITING
(May 1, 2026)
PHASE1, PHASE2
Phase ll Study of HEC585 in Patients With IPF Sunshine Lake Pharma Co., Ltd. NA ACTIVE NOT RECRUITING
(Apr 1, 2026)
PHASE2
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML Sunshine Lake Pharma Co., Ltd. NA RECRUITING
(Apr 1, 2026)
PHASE3
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF Sunshine Lake Pharma Co., Ltd. NA RECRUITING
(Apr 1, 2026)
PHASE3
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza Nanjing Zenshine Pharmaceuticals NA COMPLETED
(Apr 1, 2026)
PHASE3


Shine Drug List

Given below is the complete list of Shine's drugs and the patents protecting them.


1. Neurolite

Neurolite is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5431900 Ester-substituted diaminedithiols and radiolabeled complexes thereof 11 Jul, 2012
(14 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neurolite's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List